Biobanking Market Trends and Overview

The Biobanking Market Size was valued at USD 48.65 billion in 2022 and is projected to reach USD 86.77 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.5% during the forecast period from 2023 to 2030.

The biobanking industry has witnessed substantial growth in recent years, driven by increasing demand for high-quality biological samples and the rising prevalence of chronic diseases. Biobanks play a crucial role in collecting, storing, and managing biological specimens, such as blood, tissues, and DNA, along with associated data. These repositories serve as valuable resources for researchers, pharmaceutical companies, and healthcare providers, enabling them to conduct vital studies and develop innovative treatments.

The market's impressive growth can be attributed to several factors. Firstly, the growing emphasis on personalized medicine and precision healthcare has fueled the need for well-curated biobanks that can provide diverse and representative samples for research purposes. Additionally, advancements in biobanking technologies, including automated sample handling and storage systems, have significantly improved the efficiency and reliability of these facilities.

Furthermore, the increasing collaborations between biobanks and research institutions, as well as the rising investments in biobanking infrastructure, have further propelled market expansion. Governments and regulatory bodies worldwide are recognizing the importance of biobanks in advancing medical research and are actively supporting initiatives to enhance their capabilities.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/1753

Geographically, North America currently dominates the biobanking market, owing to the presence of well-established biobanks, robust research infrastructure, and significant investments in healthcare and life sciences. However, the Asia Pacific region is expected to witness the highest growth rate during the forecast period, driven by the increasing focus on precision medicine, rising healthcare expenditure, and expanding research capabilities.

In conclusion, the biobanking market is poised for substantial growth in the coming years, driven by the increasing demand for high-quality biological samples and the advancements in biobanking technologies.

KEY MARKET SEGMENTATION:

By Specimen type

• Solid Tissue
• Nucleic Acid
• Cell Lines
• Blood Products
• Others

By Type

• Disease-oriented
• Population

By Service

• Qualification/ Validation
• Cold Chain Logistics
• Biobanking & Repository
• Lab processing
• Other Services

By Application type

• Research
• Therapeutic

By End User

• Pharma & Biotech Companies
• Academic Institutions

Major Players Listed in the Report are as Follows:

Avantor, BioCision, Becton, Dickinson and Company (BD), Danaher Corporation, Hamilton Company, Merck KGaA, QIAGEN, Thermo Fisher Scientific, Inc., Tecan Trading AG., Taylor-Wharton and Other Players.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

[email protected],

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com